Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone
European Journal of Cancer2016Vol. 59, pp. 1–12
Citations Over TimeTop 10% of 2016 papers
Frank Traub, Janith Singh, Brendan C. Dickson, Stephanie Leung, Rakesh Mohankumar, Martin E. Blackstein, Albiruni R. Abdul Razak, Anthony M. Griffin, Peter C. Ferguson, Jay S. Wunder
Related Papers
- → RANKL inhibition halts lesion progression and promotes bone remineralization in mice with fibrous dysplasia(2021)25 cited
- → Denosumab for bone diseases: translating bone biology into targeted therapy(2011)43 cited
- → The mechanism of anti-RANKL antibody in the treatment of metabolic bone diseases including osteoporosis — possible applications of anti-RANKL antibody to the treatment of cancer patients(2019)6 cited
- → Anti-RANKL antibody was approved for the treatment of osteoporosis in Japan(2013)3 cited
- [Anti-RANKL antibody].(2015)